Eli Lilly and Company (NYSE:LLY) is one of the best future stocks to buy for the long term. On January 8, Eli Lilly announced ...

(Removes reference to GLP-1s in reference to Lilly Direct patients in paragraph 15,) By Maggie Fick and Michael Erman SAN ...

Eli Lilly said combining Taltz and Zepbound improved arthritis symptoms and drove meaningful weight loss, outperforming Taltz alone in a late-stage trial.

By Bhanvi Satija and Maggie Fick LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy weight-loss pill has made an encouraging ...

The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...

Eli Lilly (LLY) says its weight-loss pill is on track to be approved in the US, lagging behind Novo Nordisk (NVO). Eli Lilly ...

Hong Kong biotech Ascletis (HKEX: 1672) has picked ASC37 injection, a once-monthly, subcutaneous triple agonist, as a ...

Novo Nordisk NVO shares have surged 18.8% in the past month. The stock price gain was primarily induced by the ...

Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just ...

Biopharma stocks may rally in 2026 as M&A heats up and drug pricing uncertainty fades—see why UBS expects big pharma to buy biotech now—read more.

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.